A Synaptic Perspective of Fragile X Syndrome and Autism Spectrum Disorders

Claudia Bagni, R. Suzanne Zukin

Research output: Contribution to journalReview article

Abstract

Altered synaptic structure and function is a major hallmark of fragile X syndrome (FXS), autism spectrum disorders (ASDs), and other intellectual disabilities (IDs), which are therefore classified as synaptopathies. FXS and ASDs, while clinically and genetically distinct, share significant comorbidity, suggesting that there may be a common molecular and/or cellular basis, presumably at the synapse. In this article, we review brain architecture and synaptic pathways that are dysregulated in FXS and ASDs, including spine architecture, signaling in synaptic plasticity, local protein synthesis, (m)RNA modifications, and degradation. mRNA repression is a powerful mechanism for the regulation of synaptic structure and efficacy. We infer that there is no single pathway that explains most of the etiology and discuss new findings and the implications for future work directed at improving our understanding of the pathogenesis of FXS and related ASDs and the design of therapeutic strategies to ameliorate these disorders. ASDs and comorbid diseases such as FXS are caused by altered synaptic structure and connectivity. Bagni and Zukin review the construction and elimination of synapses: mild alterations in these pathways affect the equilibrium during development and cause the disease.

Original languageEnglish (US)
Pages (from-to)1070-1088
Number of pages19
JournalNeuron
Volume101
Issue number6
DOIs
StatePublished - Mar 20 2019

Fingerprint

Fragile X Syndrome
Synapses
Neuronal Plasticity
RNA Stability
Intellectual Disability
Comorbidity
Spine
Autism Spectrum Disorder
Messenger RNA
Brain
Proteins

Keywords

  • ASDs
  • ERK
  • FMRP
  • FXS
  • mGluRs
  • MNK
  • mRNA metabolism
  • mTOR
  • synaptopathies
  • TSC

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

A Synaptic Perspective of Fragile X Syndrome and Autism Spectrum Disorders. / Bagni, Claudia; Zukin, R. Suzanne.

In: Neuron, Vol. 101, No. 6, 20.03.2019, p. 1070-1088.

Research output: Contribution to journalReview article

@article{d73b5bef36174fdfb5c42f38c2f0cb33,
title = "A Synaptic Perspective of Fragile X Syndrome and Autism Spectrum Disorders",
abstract = "Altered synaptic structure and function is a major hallmark of fragile X syndrome (FXS), autism spectrum disorders (ASDs), and other intellectual disabilities (IDs), which are therefore classified as synaptopathies. FXS and ASDs, while clinically and genetically distinct, share significant comorbidity, suggesting that there may be a common molecular and/or cellular basis, presumably at the synapse. In this article, we review brain architecture and synaptic pathways that are dysregulated in FXS and ASDs, including spine architecture, signaling in synaptic plasticity, local protein synthesis, (m)RNA modifications, and degradation. mRNA repression is a powerful mechanism for the regulation of synaptic structure and efficacy. We infer that there is no single pathway that explains most of the etiology and discuss new findings and the implications for future work directed at improving our understanding of the pathogenesis of FXS and related ASDs and the design of therapeutic strategies to ameliorate these disorders. ASDs and comorbid diseases such as FXS are caused by altered synaptic structure and connectivity. Bagni and Zukin review the construction and elimination of synapses: mild alterations in these pathways affect the equilibrium during development and cause the disease.",
keywords = "ASDs, ERK, FMRP, FXS, mGluRs, MNK, mRNA metabolism, mTOR, synaptopathies, TSC",
author = "Claudia Bagni and Zukin, {R. Suzanne}",
year = "2019",
month = "3",
day = "20",
doi = "10.1016/j.neuron.2019.02.041",
language = "English (US)",
volume = "101",
pages = "1070--1088",
journal = "Neuron",
issn = "0896-6273",
publisher = "Cell Press",
number = "6",

}

TY - JOUR

T1 - A Synaptic Perspective of Fragile X Syndrome and Autism Spectrum Disorders

AU - Bagni, Claudia

AU - Zukin, R. Suzanne

PY - 2019/3/20

Y1 - 2019/3/20

N2 - Altered synaptic structure and function is a major hallmark of fragile X syndrome (FXS), autism spectrum disorders (ASDs), and other intellectual disabilities (IDs), which are therefore classified as synaptopathies. FXS and ASDs, while clinically and genetically distinct, share significant comorbidity, suggesting that there may be a common molecular and/or cellular basis, presumably at the synapse. In this article, we review brain architecture and synaptic pathways that are dysregulated in FXS and ASDs, including spine architecture, signaling in synaptic plasticity, local protein synthesis, (m)RNA modifications, and degradation. mRNA repression is a powerful mechanism for the regulation of synaptic structure and efficacy. We infer that there is no single pathway that explains most of the etiology and discuss new findings and the implications for future work directed at improving our understanding of the pathogenesis of FXS and related ASDs and the design of therapeutic strategies to ameliorate these disorders. ASDs and comorbid diseases such as FXS are caused by altered synaptic structure and connectivity. Bagni and Zukin review the construction and elimination of synapses: mild alterations in these pathways affect the equilibrium during development and cause the disease.

AB - Altered synaptic structure and function is a major hallmark of fragile X syndrome (FXS), autism spectrum disorders (ASDs), and other intellectual disabilities (IDs), which are therefore classified as synaptopathies. FXS and ASDs, while clinically and genetically distinct, share significant comorbidity, suggesting that there may be a common molecular and/or cellular basis, presumably at the synapse. In this article, we review brain architecture and synaptic pathways that are dysregulated in FXS and ASDs, including spine architecture, signaling in synaptic plasticity, local protein synthesis, (m)RNA modifications, and degradation. mRNA repression is a powerful mechanism for the regulation of synaptic structure and efficacy. We infer that there is no single pathway that explains most of the etiology and discuss new findings and the implications for future work directed at improving our understanding of the pathogenesis of FXS and related ASDs and the design of therapeutic strategies to ameliorate these disorders. ASDs and comorbid diseases such as FXS are caused by altered synaptic structure and connectivity. Bagni and Zukin review the construction and elimination of synapses: mild alterations in these pathways affect the equilibrium during development and cause the disease.

KW - ASDs

KW - ERK

KW - FMRP

KW - FXS

KW - mGluRs

KW - MNK

KW - mRNA metabolism

KW - mTOR

KW - synaptopathies

KW - TSC

UR - http://www.scopus.com/inward/record.url?scp=85062458853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062458853&partnerID=8YFLogxK

U2 - 10.1016/j.neuron.2019.02.041

DO - 10.1016/j.neuron.2019.02.041

M3 - Review article

VL - 101

SP - 1070

EP - 1088

JO - Neuron

JF - Neuron

SN - 0896-6273

IS - 6

ER -